avenzoarpharmaceuticals.com | Home

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.avenzoarpharmaceuticals.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change

Meta Tags

Title	Home \| Avenzoar
Description	ABOUT top of page AVENZOAR PHARMACEUTICALS Home Products Home: About ABOUT AVENZOAR Avenzoar Pharmaceuticals is a start-up pharmaceutical company founded in 201
Keywords	Everything, Have, Need, We

Server Information

WebSite	avenzoarpharmaceuticals.com
Host IP	185.230.63.186
Location	-

Related Websites

                        Site
                        Rank
                    

More to Explore

avenzoarpharmaceuticals.com Valuation

US$1,795,885

Last updated: 2023-05-18 00:23:30

avenzoarpharmaceuticals.com has Semrush global rank of 5,893,643. avenzoarpharmaceuticals.com has an estimated worth of US$ 1,795,885, based on its estimated Ads revenue. avenzoarpharmaceuticals.com receives approximately 207,218 unique visitors each day. Its web server is located in -, with IP address 185.230.63.186. According to SiteAdvisor, avenzoarpharmaceuticals.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$1,795,885
Daily Ads Revenue	US$1,658
Monthly Ads Revenue	US$49,733
Yearly Ads Revenue	US$596,787
Daily Unique Visitors	13,815
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
avenzoarpharmaceuticals.com. 3600 IN	A		IP: 185.230.63.186
avenzoarpharmaceuticals.com. 3600 IN	A		IP: 185.230.63.171
avenzoarpharmaceuticals.com. 3600 IN	A		IP: 185.230.63.107
avenzoarpharmaceuticals.com. 21600 IN	NS		NS Record: ns6.wixdns.net.
avenzoarpharmaceuticals.com. 21600 IN	NS		NS Record: ns7.wixdns.net.

HtmlToTextCheckTime:2023-05-18 00:23:30

top of page AVENZOAR PHARMACEUTICALS Home Products Home: About ABOUT AVENZOAR Avenzoar Pharmaceuticals is a start-up pharmaceutical company founded in 2016. Avenzoar is specialized in developing cancer drugs aiming at targeting and inhibiting mechanisms of metastasis and drug resistance. Avenzoar has 3 drugs in the pipeline so far. The lead drug is AP-001 (aka Metavert), which is expected to be tested in pancreatic cancer patients in 2024/2025. Contact Home: Welcome AVENZOAR Committed to fight cancer Avenzoar’s management team: Terrance Bruggeman, MBA, Chief Executive Officer , has served as Executive Chairman and as Chief Executive Officer of a number of life sciences including Diversa (1992-2000) (IPO), Provasis Therapeutics (2000-2002) which was sold to Boston Scientific, Somanta Pharmaceuticals (2004-2008) reverse merger and IPO and BioTork (2009-2016) . Stephen Pandol, MD, Director, Founder, and Chief Medical Officer, is the Director of Basic and Translational Pancreas

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Sat, 30 Apr 2022 08:26:42 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.avenzoarpharmaceuticals.com/
strict-transport-security: max-age=3600
Age: 66591
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=84
X-Seen-By: qdrMdw4zrP0/E6B8JtgqKA==,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVg6ziUdApsXuvLrb25A0tjf,m0j2EEknGIVUW/liY8BLLmgaK4Uo/c64tu5tjs2/gqUlJk2S3kV4GhWnrhiCH1G7,2d58ifebGbosy5xc+FRalrietaPgVTHXiIaVfg7EabVT+z9Q8xdg03KL9T7WigYqF1Z73EET5eCGpnpRdtcbBg==,2UNV7KOq4oGjA5+PKsX47L/w64C2MEzM6m+Hxfbfe91YgeUJqUXtid+86vZww+nL
Cache-Control: no-cache
X-Wix-Request-Id: 1651307202.97053303673937684
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Sat, 30 Apr 2022 08:26:43 GMT
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
x-wix-request-id: 1651307203.181568035321631633
content-language: en
strict-transport-security: max-age=3600
age: 0
x-seen-by: GXNXSWFXisshliUcwO20NXdyD4zpCpFzpCPkLds0yMe9gmGV3i2110EgwJ+21Lv0,qquldgcFrj2n046g4RNSVOEcKTWnPkUHK4qOWpouMik=,2d58ifebGbosy5xc+FRalvCOj1jsLT4I8XpwZ+1GmowsHi+/meNNrDP1P3fAKMNzXjasSmn6KEfJMcGqErZkCH0nk0s4yOzP+tX0xomJRb8=,2UNV7KOq4oGjA5+PKsX47Dup3Er3OeJdBpGMGRuuaaaa46R9xNIlpQ4eUPYpBuqs,7npGRUZHWOtWoP0Si3wDp5OwruH0a9zNM2Yc5shRAns=,0roNRkh2xJh7V8AO49Mmo4zu2pofvYNDn0TBDnDweXquDWfWi29lojYYkv8YXaxd+wcUeDSTBd2YB/cfy/qzdw==,xTu8fpDe3EKPsMR1jrheEBHeNYTD2sTnaVoXDSTmJcM=,LoUK8/saGAmOxZWtpubo2nxCJA0fbhwSxwGigZZi9g05RJAukc6qUbGqZWNKHz3jg6Q2RccXanhJ7qtmcUFwng==,xTu8fpDe3EKPsMR1jrheEFeWivEBUZzpQB6K3XkdG8A=,xTu8fpDe3EKPsMR1jrheEN2lHZkpZdh5ghEJ72dEfoo=,/a5ccLSK1HEmwPNg/x6Oug7IbX0ZIxzsailoxRA1tEAqcyE63WrKknrqwt1xTAqcRQ/asdhtHlRScuWcXvX4Yg==
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
set-cookie: ssr-caching=cache#desc=miss#varnish=miss#dc#desc=eun1_g; Max-Age=20; Expires=Sat, 30 Apr 2022 08:27:03 GMT
server-timing: cache;desc=miss, varnish;desc=miss, dc;desc=eun1_g
x-content-type-options: nosniff
server: Pepyaka/1.19.10
via: 1.1 google
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"

avenzoarpharmaceuticals.com Whois Information

Domain Name: AVENZOARPHARMACEUTICALS.COM
Registry Domain ID: 2284625655_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2020-06-12T01:21:35Z
Creation Date: 2018-07-12T01:05:46Z
Registry Expiry Date: 2022-07-12T01:05:46Z
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS6.WIXDNS.NET
Name Server: NS7.WIXDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2022-04-30T09:04:29Z <<<

avenzoarpharmaceuticals.com valuation and analysis